Godavari Drugs (BOM:530317) Beta: 0.7289 (As of Aug. 12, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530317 Godavari Drugs Ltd BOM:530317
54 GF Score
Price ₹102.50
GF Value ₹72.37
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Godavari Drugs Beta?

Godavari Drugs BOM:530317 -0.49% 54 Beta is 0.7289 as of Aug. 12, 2026. GuruFocus rates BOM:530317 with a GF Score™ of 54/100 and a GF Value™ of ₹72.37 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-12), Godavari Drugs's Beta is 0.7289.


Godavari Drugs  (BOM:530317) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Godavari Drugs Beta Related Terms


Godavari Drugs Beta Historical Data

* Premium members only.

The historical data trend for Godavari Drugs's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Godavari Drugs Beta Chart

Godavari Drugs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.37 0.96 0.41 0.73 0.48

Godavari Drugs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 0.67 0.63 1.31 0.48

BOM:530317 vs ZTS: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Godavari Drugs's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Godavari Drugs Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Godavari Drugs's Beta distribution charts can be found below:

* The bar in red indicates where Godavari Drugs's Beta falls into.


BOM:530317
54GF Score
Godavari Drugs Ltd BOM:530317
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Godavari Drugs Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.7289 mean?
Godavari Drugs (BOM:530317) has a Beta of 0.7289 as of Aug. 12, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Godavari Drugs and its competitors.
Is Godavari Drugs' Beta too high?
Godavari Drugs' current Beta is 0.7289. Overall, Godavari Drugs has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Godavari Drugs' Beta compare to ZTS?
Godavari Drugs' Beta of 0.7289 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Godavari Drugs and its competitors. Godavari Drugs's current Beta is 0.7289. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Godavari Drugs stock overvalued right now?
Based on GuruFocus' analysis, Godavari Drugs (BOM:530317) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹72.37, compared to a current price of ₹102.50 — trading 41.6% above its estimated fair value. The current Beta is 0.7289. Godavari Drugs' overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Godavari Drugs (BOM:530317), the current Beta is 0.7289 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Godavari Drugs (BOM:530317) Overvalued in 2026?

Based on GuruFocus' analysis, Godavari Drugs stock appears to be overvalued. The current stock price of ₹102.50 is trading 41.6% above its estimated GF Value™ of ₹72.37. GuruFocus considers Godavari Drugs to be Significantly Overvalued.

Key valuation signals for BOM:530317:

  • Beta: 0.7289
  • GF Value™: ₹72.37 vs. price of ₹102.50 (41.6% above fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the BOM:530317 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Godavari Drugs Business Description

Address Sardar Patel Road, 1-8-303/34, Mayfair, 1st Floor, Secunderabad, TG, IND, 500 003
Godavari Drugs Ltd is an India-based pharmaceutical company. It is principally engaged in manufacturing of APl's, intermediates and fine chemicals,. The firm's product includes Ciprofloxacin hydrochloride, ciprofloxacin, ciprofloxacin lactate, ciprofloxacin lactate, and Others. The company operates only one segment which is the manufacture and sale of Active Pharmaceutical Ingredients (API) and its intermediates.
54GF Score

Get the complete analysis for BOM:530317

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹102.50
Price
₹72.37
GF Value